Image

The Clorox Company (CLX) Q2 2026 Earnings Call Transcript

The Clorox Company (CLX) Q2 2026 Earnings Call February 3, 2026 5:00 PM EST

Company Participants

Lisah Burhan – Vice President of Investor Relations
Linda Rendle – CEO & Chairman
Luc Bellet – Executive VP & CFO

Conference Call Participants

Andrea Teixeira – JPMorgan Chase & Co, Research Division
Peter Grom – UBS Investment Bank, Research Division
Filippo Falorni – Citigroup Inc., Research Division
Javier Escalante Manzo – Evercore ISI Institutional Equities, Research Division
Bonnie Herzog – Goldman Sachs Group, Inc., Research Division
Anna Lizzul – BofA Securities, Research Division
Kevin Grundy – BNP Paribas, Research Division
Olivia Tong Cheang – Raymond James & Associates, Inc., Research Division
Kaumil Gajrawala – Jefferies LLC, Research Division
Lauren Lieberman – Barclays Bank PLC, Research Division
Edward Lewis – Rothschild & Co Redburn, Research Division
Robert Moskow – TD Cowen, Research Division
Christopher Carey – Wells Fargo Securities, LLC, Research Division

Presentation

Operator

Good day, ladies and gentlemen, and welcome to the Clorox Company Second Quarter Fiscal Year 2026 Earnings Release Conference Call. [Operator Instructions] As a reminder, this call is being recorded.

I would now like to introduce your host for today’s conference call, Ms. Lisah Burhan, Vice President of Investor Relations for the Clorox Company. Ms. Burhan, you may begin your conference.

Lisah Burhan
Vice President of Investor Relations

Thanks, Jen. Joining me today are Chair and CEO, Linda Rendle; and CFO, Luc Bellet.

The following remarks include forward-looking statements that are based on management’s current expectations, but may differ from actual results or outcomes. In addition, these remarks refer to certain non-GAAP financial measures. Please refer to CLX’s earnings release, which identifies various factors that could affect forward-looking statements and provide information that reconciles non-GAAP financial measures to the most directly comparable GAAP measures. The Risk Factors section of the company’s Form 10-K also includes further discussion of forward-looking statements.

With that, I’ll

SHARE THIS POST